Hexal Overview
- Year Founded
-
1986
- Status
-
Acquired/Merged
- Employees
-
3,400
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
- Investments
-
3
Hexal General Information
Description
Manufacturer of generic pharmaceuticals designed for affordable healthcare provision. The company offers generic medicines, biosimilars, over-the-counter products, oncology treatments, cardiovascular drugs, and pain management medications, thereby enabling healthcare providers to access affordable versions of essential prescription and over-the-counter medications through innovative drug delivery systems.
Contact Information
Website
www.hexal.de(Operating Subsidiary)
Corporate Office
- Industriestraße 25
- 83607 Holzkirchen
- Germany
Corporate Office
- Industriestraße 25
- 83607 Holzkirchen
- Germany
Hexal Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Hexal Patents
Hexal Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4008345-A1 | Novel formulations for antibodies | Inactive | 03-Dec-2020 | ||
| EP-4255479-A1 | Novel formulations for antibodies | Inactive | 03-Dec-2020 | ||
| US-20240052030-A1 | Novel formulations for antibodies | Inactive | 03-Dec-2020 | ||
| WO-2022117795-A1 | Novel formulations for antibodies | Inactive | 03-Dec-2020 | ||
| WO-2019106043-A1 | Pharmaceutical composition comprising obeticholic acid | Inactive | 29-Nov-2017 | A61K9/08 |
Hexal Signals
Hexal Investments & Acquisitions (3)
Hexal’s most recent deal was a Later Stage VC with Glycotope for . The deal was made on 03-Nov-2007.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Glycotope | 03-Nov-2007 | Later Stage VC | Drug Discovery | ||
| Eon Labs | 01-Dec-2000 | Secondary Transaction - Private | Pharmaceuticals | ||
| Eon Labs | 01-Jan-1995 | Merger/Acquisition | Pharmaceuticals |
Hexal Exits (3)
Hexal’s most recent exit was on 03-Nov-2007 from Glycotope. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Glycotope | 03-Nov-2007 | Completed |
|
||
| Eon Labs | 01-Dec-2000 | Completed |
|
||
| Eon Labs | 01-Jan-1995 | Merger/Acquisition | Completed |
Hexal Affiliates
Subsidiaries (3)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| 1 A Pharma | Oberhaching, Germany | 1997 | |
| Salutas Pharma | Barleben, Germany | 1993 | |
| Aeropharm | Rudolstadt, Germany | 1992 |
Hexal FAQs
-
When was Hexal founded?
Hexal was founded in 1986.
-
Where is Hexal headquartered?
Hexal is headquartered in Holzkirchen, Germany.
-
What is the size of Hexal?
Hexal has 3,400 total employees.
-
What industry is Hexal in?
Hexal’s primary industry is Pharmaceuticals.
-
Is Hexal a private or public company?
Hexal is a Private company.
-
What is the current valuation of Hexal?
The current valuation of Hexal is .
-
What is Hexal’s current revenue?
The current revenue for Hexal is .
-
When was Hexal acquired?
Hexal was acquired on 06-Jun-2005.
-
Who acquired Hexal?
Hexal was acquired by Sandoz.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process